logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
V

Victoria Bray

Westmead Hospital
H指数:21
被引数:3,052
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Histopathological associations, molecular findings and clinical outcomes of patients with non-small cell lung carcinoma with MET alterations: a 3 year retrospective Australian case series

非小细胞肺癌患者中MET基因改变相关的组织病理学关联、分子发现及临床结局：一项为期3年的澳大利亚病例回顾系列研究

Pathology
IF5.2
2025-10-240
PRE
Jing Jing Li; Jawad Saab; Victoria Bray; Jonathan Williamson; Abhijit Pal; Po Yee Yip; Pei Ding; Shalini K. Vinod; Bruce French; Chee Lee; Ruta Gupta; Wendy A. Cooper; Bin Wang; C.Soon Lee
Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation-Positive NSCLC An Open-Label Phase 2 Trial (ILLUMINATE)

Durvalumab，Tremelimumab和铂类化疗在EGFR突变阳性NSCLC中的应用开放标签2期试验 (illumate)

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2025-02-010
OA
Lee, Chee Khoon; Liao, Bin-Chi; Subramaniam, Shalini; Chiu, Chao-Hua; Mersiades, Antony; Ho, Chao-Chi; Brown, Chris; Lai, Chun-Liang; Hughes, Brett G. M.; Yang, Tsung-Ying; O'Byrne, Ken; Luo, Yung-Hung; Yip, Sonia; Ho, Ching-Liang; Bray, Victoria; Su, Wu-Chou; Moore, Melissa; Feng, Wei-Lien; Bai, Ya-Ying; Ford, Kate; Cummins, Michelle M.; Stockler, Martin R.; Solomon, Benjamin J.; John, Thomas; Yang, James Chih-Hsin
ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance

ALKTERNATE: 一项在ALK阳性NSCLC中交替使用氯拉替尼和克唑替尼的初步研究

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2024-09-010
OA
Itchins, Malinda; Liang, Shirley; Brown, Chris; Barnes, Tristan; Marx, Gavin; Chin, Venessa; Kao, Steven; Yip, Po Yee; Mersiades, Antony J.; Nagrial, Adnan; Bray, Victoria; Peters, Geoffrey; Parakh, Sagun; Garg, Kavita; Li, Bob T.; Mckay, Matthew; O'Byrne, Kenneth; John, Thomas; Gill, Anthony J.; Molloy, Mark P.; Solomon, Benjamin J.; Pavlakis, Nick
Real world efficacy and toxicity of consolidation durvalumab following chemoradiotherapy in older Australian patients with unresectable stage III non-small cell lung cancer

澳大利亚老年不可切除的III期非小细胞肺癌患者放化疗后巩固durvalumab的真实世界疗效和毒性

JOURNAL OF GERIATRIC ONCOLOGY
IF2.7
2024-03-015
OA
Stevens, Samuel; Nindra, Udit; Shahnam, Adel; Wei, Joe; Bray, Victoria; Pal, Abhijit; Yip, Po Yee; Linton, Anthony; Blinman, Prunella; Nagrial, Adnan; Lee, Jenny; Boyer, Michael; Kao, Steven
A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE

奥希替尼和吉非替尼交替治疗晚期EGFR-T790M阳性非小细胞肺癌的II期试验: 振荡

NATURE COMMUNICATIONS
IF15.7
2024-02-286
OAAI
Tan, Lavinia; Brown, Chris; Mersiades, Antony; Lee, Chee Khoon; John, Thomas; Kao, Steven; Newnham, Genni; O'Byrne, Kenneth; Parakh, Sagun; Bray, Victoria; Jasas, Kevin; Yip, Sonia; Wong, Stephen Q.; Ftouni, Sarah; Guinto, Jerick; Chandrashekar, Sushma; Clarke, Stephen; Pavlakis, Nick; Stockler, Martin R.; Dawson, Sarah-Jane; Solomon, Benjamin J.
Plasma pre-treatment T790M relative allelic frequency in patients with advanced EGFR-mutated non-small cell lung cancer predicts treatment response to subsequent-line osimertinib

晚期EGFR突变的非小细胞肺癌患者治疗前血浆T790M相对等位基因频率预测对后续奥希替尼的治疗反应

TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2021-04-016
OAAI
Ding, Pei N.; Roberts, Tara L.; Chua, Wei; Becker, Therese M.; Caixeiro, Nicole; de Souza, Paul; Gao, Bo; Lee, Chee K.; Itchins, Malinda; Westman, Helen; Clarke, Stephen; Blinman, Prunella; Kao, Steven; John, Tom; Leal, Jose L.; Bray, Victoria J.

研究方向

暂未获取到该数据
J
Janette L. Vardy
H 指数:55论文数:258被引数:1.1万
H
Haryana M. Dhillon
H 指数:48论文数:379被引数:9,906
M
Melanie L. Bell
H 指数:56论文数:270被引数:1.0万
A
Abhijit Pal
H 指数:15论文数:76被引数:848
P
Po Yee Yip
H 指数:14论文数:40被引数:992
C
Chee Khoon Lee
H 指数:42论文数:302被引数:1.2万
S
Stephen Clarke
H 指数:79论文数:719被引数:3.0万
B
Benjamin Solomon
H 指数:98论文数:825被引数:6.3万
T
Thomas John
H 指数:66论文数:530被引数:2.9万
W
Wei Chua
H 指数:30论文数:136被引数:4,979